VYEPTI is a prescription medicine used for the preventive treatment of migraine in adults.

Eptinezumab-jjmr is a humanized immunoglobulin G1 (IgG1) monoclonal antibody specific for calcitonin gene-related peptide (CGRP) ligand. Eptinezumab-jjmr has an approximate molecular weight of 143 kD. Eptinezumab-jjmr is produced in Pichia pastoris yeast cells by recombinant DNA technology.

Vyepti Info

Vyepti is a 30-minute intravenous (IV) treatment given 4 times per year (every 3 months).

The recommended dosage is 100 mg administered by intravenous infusion every 3 months. Some patients may benefit from a dosage of 300 mg administered by intravenous infusion every 3 months.

Vyepti Side Effects

The most common side effects include: 

  • stuffy nose and scratchy throat
  • allergic reactions


Patient Assistance Programs

There are several programs patients can sign up for that will assist in treatment costs:


To learn more about this treatment, browse the resources below.

Order Form

To download the order form for this treatment, click below.

Ready to get started?

Contact us to chat with one of our helpful scheduling specialists!